-+ 0.00%
-+ 0.00%
-+ 0.00%

PTC Therapeutics Board Authorizes Share Repurchases of Up to $500 Million

PUBT·11/03/2026 12:14:39
PTC Therapeutics Board Authorizes Share Repurchases of Up to $500 Million
  • PTC Therapeutics' board authorized a share repurchase program today covering up to $500 million of outstanding common stock.
  • Repurchases are subject to market conditions and may be made from time to time at management's discretion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PTC Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611030700PR_NEWS_USPR_____NY87398) on November 03, 2026, and is solely responsible for the information contained therein.